title: High resolution quantitative proteomics of HeLa cells protein species using stable isotope labeling with amino acids in cell culture(SILAC), two-dimensional gel electrophoresis(2DE) and nano-liquid chromatograpohy coupled to an LTQ-OrbitrapMass spectrometer.
abstract: The proteomics field has shifted over recent years from two-dimensional gel electrophoresis (2-DE)-based approaches to SDS-PAGE or gel-free workflows because of the tremendous developments in isotopic labeling techniques, nano-liquid chromatography, and high-resolution mass spectrometry. However, 2-DE still offers the highest resolution in protein separation. Therefore, we combined stable isotope labeling with amino acids in cell culture of controls and apoptotic HeLa cells with 2-DE and the subsequent analysis of tryptic peptides via nano-liquid chromatography coupled to an LTQ-Orbitrap mass spectrometer to obtain quantitative data using the methods with the highest resolving power on all levels of the proteomics workflow. More than 1,200 proteins with more than 2,700 protein species were identified and quantified from 816 Coomassie Brilliant Blue G-250 stained 2-DE spots. About half of the proteins were identified and quantified only in single 2-DE spots. The majority of spots revealed one to five proteins; however, in one 2-DE spot, up to 23 proteins were identified. Only half of the 2-DE spots represented a dominant protein with more than 90% of the whole protein amount. Consequently, quantification based on staining intensities in 2-DE gels would in approximately half of the spots be imprecise, and minor components could not be quantified. These problems are circumvented by quantification using stable isotope labeling with amino acids in cell culture. Despite challenges, as shown in detail for lamin A/C and vimentin, the quantitative changes of protein species can be detected. The combination of 2-DE with high-resolution nano-liquid chromatography-mass spectrometry allowed us to identify proteomic changes in apoptotic cells that would be unobservable using any of the other previously employed proteomic workflows.
authors.affiliation: The Biotechnology Centre of Oslo, University of Oslo, Gaustadalleen 21, 0349 Oslo, Norway. bernd.thiede@biotek.uio.no
authors.forename: Bernd
authors.initials: B
authors.lastname: Thiede
authors.forename: Christian J
authors.initials: CJ
authors.lastname: Koehler
authors.forename: Margarita
authors.initials: M
authors.lastname: Strozynski
authors.forename: Achim
authors.initials: A
authors.lastname: Treumann
authors.forename: Robert
authors.initials: R
authors.lastname: Stein
authors.forename: Ursula
authors.initials: U
authors.lastname: Zimny-Arndt
authors.forename: Monika
authors.initials: M
authors.lastname: Schmid
authors.forename: Peter R
authors.initials: PR
authors.lastname: Jungblut
mesh_terms: D017209:Apoptosis / Q000187:drug effects; D016477:Artifacts; D002853:Chromatography, Liquid; D003545:Cysteine / Q000031:analogs & derivatives / Q000494:pharmacology; D015180:Electrophoresis, Gel, Two-Dimensional; D006367:HeLa Cells; D006801:Humans; D007553:Isotope Labeling; D013058:Mass Spectrometry; D010455:Peptides / Q000032:analysis; D020543:Proteome / Q000235:genetics* / Q000378:metabolism; D040901:Proteomics; D012394:Rosaniline Dyes
chemical_list: D010455:Peptides; D020543:Proteome; D012394:Rosaniline Dyes; C003724:3-tritylthio-L-alanine; D003545:Cysteine; C004692:coomassie Brilliant Blue